EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Momordicine I suppresses glioma growth by promoting apoptosis and impairing mitochondrial oxidative phosphorylation

Ying Kao, Chung-Hsing Chou, Li-Chun Huang, Chia-Kuang Tsai

EXCLI Journal · 06.06.2023 · 22 · 482-498

DOI: 10.17179/excli2023-6129 ↗

Kurz gefasst

Fachartikel in der Zeitschrift EXCLI Journal, online erschienen am 06.06.2023. Verfasst von Ying Kao und 3 weiteren Autor:innen. Beteiligte Einrichtung: Division of Neurosurgery, Department of Surgery, Taipei City Hospital Zhongxing Branch, Taipei 10341, Taiwan. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Glioblastoma (GBM) is the most common type of primary brain tumor. Patients with GBM have poor survival outcomes. Isolated components of Momordica charantia have anticancer effects. However, the bioactivity of M. charantia extracts against GBM remains unknown. We tested four major extracts of M. charantia and found that momordicine I reduced glioma cell viability without serious cytotoxic effects on astrocytes. Momordicine I suppressed glioma cell colony formation, proliferation, migration, and invasion. Momordicine I also induced apoptosis, intracellular reactive oxygen species (ROS) production, and senescence in glioma cells. Moreover, momordicine I decreased the oxidative phosphorylation capacity of glioma cells and inhibited tumor sphere formation in temozolomide (TMZ)-resistant GBM cells. We further explored whether the antiglioma effect of momordicine I may be related to cell cycle modulation and DLGPA5 expression. Our results indicate that the cytotoxic effect of momordicine I on glioma cells suggests its potential therapeutic application to GBM treatment.

Schlagwörter

Stichwörter der Autor:innen

DLGPA5Momordica charantiaMomordicine Iglioblastomaoxidative phosphorylation capacity

Autor:innen und Institutionen

  • Division of Neurosurgery, Department of Surgery, Taipei City Hospital Zhongxing Branch, Taipei 10341, Taiwan.
  • Taipei City University, Taipei 100234, Taiwan.
  • Department of Neurology, Tri-Service General Hospital, National Defense Medical Center, Taipei 11490, Taiwan.
  • Department of Biochemistry, National Defense Medical Center, Taipei 11490, Taiwan.

Zitieren

APA

Kao, Y., Chou, C. H., Huang, L. C., & Tsai, C. K. (2023). Momordicine I suppresses glioma growth by promoting apoptosis and impairing mitochondrial oxidative phosphorylation. EXCLI Journal, 22, 482-498. https://doi.org/10.17179/excli2023-6129

Vancouver

Kao Y, Chou CH, Huang LC, Tsai CK. Momordicine I suppresses glioma growth by promoting apoptosis and impairing mitochondrial oxidative phosphorylation. EXCLI Journal. 2023;22:482-498. doi:10.17179/excli2023-6129

BibTeX
@article{Kao2023,
  author = {Kao, Ying and Chou, Chung-Hsing and Huang, Li-Chun and Tsai, Chia-Kuang},
  title = {Momordicine I suppresses glioma growth by promoting apoptosis and impairing mitochondrial oxidative phosphorylation},
  journal = {EXCLI Journal},
  year = {2023},
  volume = {22},
  pages = {482--498},
  doi = {10.17179/excli2023-6129}
}
Kostenlos starten →